Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MBNL3 anticorps (AA 116-211)

L’anticorps Lapin Polyclonal anti-MBNL3 a été validé pour ELISA, IHC et IF. Il convient pour détecter MBNL3 dans des échantillons de Humain.
N° du produit ABIN7160361

Aperçu rapide pour MBNL3 anticorps (AA 116-211) (ABIN7160361)

Antigène

Voir toutes MBNL3 Anticorps
MBNL3 (Muscleblind-Like Splicing Regulator 3 (MBNL3))

Reactivité

  • 25
  • 2
Humain

Hôte

  • 24
  • 2
Lapin

Clonalité

  • 25
  • 1
Polyclonal

Conjugué

  • 12
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp MBNL3 est non-conjugé

Application

  • 15
  • 12
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
  • Épitope

    • 7
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 116-211

     Réactivité croisée

    Humain

    Purification

    >95%, Protein G purified

    Immunogène

    Recombinant Human Muscleblind-like protein 3 protein (116-211AA)

    Isotype

    IgG
  • Indications d'application

    Recommended dilution: IHC:1:200-1:500, IF:1:50-1:200,

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène

    MBNL3 (Muscleblind-Like Splicing Regulator 3 (MBNL3))

    Autre désignation

    MBNL3

    Sujet

    Background: Mediates pre-mRNA alternative splicing regulation. Acts either as activator or repressor of splicing on specific pre-mRNA targets. Inhibits cardiac troponin-T (TNNT2) pre-mRNA exon inclusion but induces insulin receptor (IR) pre-mRNA exon inclusion in muscle. Antagonizes the alternative splicing activity pattern of CELF proteins. May play a role in myotonic dystrophy pathophysiology (DM). Could inhibit terminal muscle differentiation, acting at approximately the time of myogenin induction.

    Aliases: A530038J18Rik antibody, AI661274 antibody, CHCR antibody, Cys3His CCG1 required protein antibody, Cys3His CCG1-required protein antibody, E430034C16Rik antibody, MBLX antibody, MBLX39 antibody, MBNL 3 antibody, Mbnl3 antibody, MBNL3_HUMAN antibody, MBXL antibody, Muscleblind like 3 antibody, Muscleblind like protein 3 antibody, Muscleblind like splicing regulator 3 antibody, Muscleblind like X linked protein antibody, Muscleblind-like protein 3 antibody, Muscleblind-like X-linked protein antibody, OTTMUSP00000019072 antibody, OTTMUSP00000019073 antibody, OTTMUSP00000019074 antibody, Protein HCHCR antibody, RP23-98P13.1 antibody

    UniProt

    Q9NUK0

    Pathways

    Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Vous êtes ici:
Chat with us!